Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-07

FDA Approved: LACOSAMIDE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved Sagent Pharmaceuticals' original application for lacosamide (generic), enabling marketing of a generic lacosamide product for seizure treatment. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)